×

product

Obeticholic Acid

  • CAS No: 459789-99-2
  • Appearance : White to off-white crystalline powder
  • Assay : ≥99.0%
  • Molecular Formula: C26H44O4
  • Molecular Weight: 420.625
  • OEM ODM available

    Feature

    Obeticholic acid (OCA) is a semisynthetic bile acid derivative, whose structure consists of a β-steroid nucleus and four substituents.
    It is a first-line farnesyl ester X receptor (FXR) agonist. Its ability to activate FXR is 100 times stronger than that of another commonly used drug, UDCA.
    The drug was approved for marketing by the FDA and the European Union in 2016, and is the first drug approved for the treatment of PBC in nearly 20 years.

    Specification-COA

    Test ItemSpecificationResults
    Assay98.0% ~ 102.0% (Calculated on the anhydrous basis)98.6%
    AppearanceWhite to almost white solidWhite solid
    IdentificationThe retention time of the major peak of the Sample
    solution corresponds to that of the Standard solution,as obtained in the Assay.
    Conforms
    Water≤ 2.0%1.4%
    Heavy metal≤ 20 ppmConforms
    Related substancesACS9037-1 ≤ 0.15%0.04%
    ACS9037-9 ≤ 0.15%Negative
    Other single impurity ≤ 0.15%0.08%
    Total impurities ≤ 1 %0.18%
    Residual solventHeptane ≤ 0.5%Negative
    Methylene chloride ≤ 0.06%Negative
    Ethyl acetate ≤ 0.5%Negative
    Acetonitrile ≤ 0.041%0.0045%
    Toluene ≤ 0.089%Negative
    Conclusion:Meet the standard

    What is obeticholic acid used for?

    Obeticholic acid is a globally marketed drug used to treat:

    1. Primary biliary cirrhosis (PBC).
    2. Non-alcoholic fatty liver disease (NASH).
    3. Primary sclerosing cholangitis.
      In addition, there are multiple indications in clinical research, including primary sclerosing cholangitis (PSC), non-alcoholic steatohepatitis (NASH), and biliary atresia.

    Related Products

    View All